Plasma Circulating Tumor DNA Levels for the Monitoring of Melanoma Patients: Landscape of Available Technologies and Clinical Applications

Melanoma is a cutaneous cancer with an increasing worldwide prevalence and high mortality due to unresectable or metastatic stages. Mutations in BRAF, NRAS, or KIT are present in more than 60% of melanoma cases, but a useful blood-based biomarker for the clinical monitoring of melanoma patients is s...

Descripción completa

Detalles Bibliográficos
Autores principales: Busser, Benoit, Lupo, Julien, Sancey, Lucie, Mouret, Stéphane, Faure, Patrice, Plumas, Joel, Chaperot, Laurence, Leccia, Marie Thérèse, Coll, Jean Luc, Hurbin, Amandine, Hainaut, Pierre, Charles, Julie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2017
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5397613/
https://www.ncbi.nlm.nih.gov/pubmed/28484715
http://dx.doi.org/10.1155/2017/5986129

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5397613/
https://www.ncbi.nlm.nih.gov/pubmed/28484715
http://dx.doi.org/10.1155/2017/5986129

Ejemplares similares